Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness BPC 157 penis enlargement: What the evidence and real world experience actually show The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. FDA to weigh easing limits on unproven peptides